What is Shaver Pharmacy?
Shaver Pharmacy and Compounding Center operates as a critical healthcare provider, distinguishing itself through a comprehensive suite of services that extend beyond traditional pharmaceutical offerings. The company is a recognized provider of oxygen therapy, maintaining a specialized inventory that includes oxygen concentrators and portable units. With HQAA accreditation, the firm ensures that its clinical staff is equipped to manage complex in-home setups, delivery, and ongoing maintenance. This operational model is fully integrated with Medicare, Medicaid, and private insurance frameworks, establishing the company as a reliable partner for patients requiring consistent, high-quality respiratory support and compounding solutions.
How much funding has Shaver Pharmacy raised?
Shaver Pharmacy has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Shaver Pharmacy
PPP
Public-Private Partnership
What's next for Shaver Pharmacy?
With the recent capital injection, Shaver Pharmacy is poised to scale its operational capacity and deepen its penetration within the regional healthcare market. The strategic focus will likely center on optimizing supply chain logistics for its oxygen therapy division and expanding its compounding capabilities to meet rising demand. As the company navigates this late-stage growth phase, the emphasis will remain on maintaining rigorous accreditation standards while scaling its patient-centric service model. Future initiatives may involve technological upgrades to its in-home delivery systems and potential expansion of its service footprint to reach underserved demographics within the broader Idaho region, ensuring long-term sustainability and competitive advantage.
See full Shaver Pharmacy company page
